skip to main content


Title: Global Change and Emerging Infectious Diseases
Our world is undergoing rapid planetary changes driven by human activities, often mediated by economic incentives and resource management, affecting all life on Earth. Concurrently, many infectious diseases have recently emerged or spread into new populations. Mounting evidence suggests that global change—including climate change, land-use change, urbanization, and global movement of individuals, species, and goods—may be accelerating disease emergence by reshaping ecological systems in concert with socioeconomic factors. Here, we review insights, approaches, and mechanisms by which global change drives disease emergence from a disease ecology perspective. We aim to spur more interdisciplinary collaboration with economists and identification of more effective and sustainable interventions to prevent disease emergence. While almost all infectious diseases change in response to global change, the mechanisms and directions of these effects are system specific, requiring new, integrated approaches to disease control that recognize linkages between environmental and economic sustainability and human and planetary health. Expected final online publication date for the Annual Review of Resource Economics, Volume 14 is October 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.  more » « less
Award ID(s):
2011147
NSF-PAR ID:
10349779
Author(s) / Creator(s):
; ; ; ;
Date Published:
Journal Name:
Annual Review of Resource Economics
Volume:
14
Issue:
1
ISSN:
1941-1340
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Humans live in complex socio-ecological systems where we interact with parasites and pathogens that spend time in abiotic and biotic environmental reservoirs (e.g., water, air, soil, other vertebrate hosts, vectors, intermediate hosts). Through a synthesis of published literature, we reviewed the life cycles and environmental persistence of 150 parasites and pathogens tracked by the World Health Organization's Global Burden of Disease study. We used those data to derive the time spent in each component of a pathogen's life cycle, including total time spent in humans versus all environmental stages. We found that nearly all infectious organisms were “environmentally mediated” to some degree, meaning that they spend time in reservoirs and can be transmitted from those reservoirs to human hosts. Correspondingly, many infectious diseases were primarily controlled through environmental interventions (e.g., vector control, water sanitation), whereas few (14%) were primarily controlled by integrated methods (i.e., combining medical and environmental interventions). Data on critical life history attributes for most of the 150 parasites and pathogens were difficult to find and often uncertain, potentially hampering efforts to predict disease dynamics and model interactions between life cycle time scales and infection control strategies. We hope that this synthetic review and associated database serve as a resource for understanding both common patterns among parasites and pathogens and important variability and uncertainty regarding particular infectious diseases. These insights can be used to improve systems-based approaches for controlling environmentally mediated diseases of humans in an era where the environment is rapidly changing. 
    more » « less
  2. Abstract

    Infectious diseases are a major threat to global human health, yet prophylactic treatment options can be limited, as safe and efficacious vaccines exist only for a fraction of all diseases. Notably, devastating diseases such as acquired immunodeficiency syndrome (AIDS) and coronavirus disease of 2019 (COVID‐19) currently do not have vaccine therapies. Conventional vaccine platforms, such as live attenuated vaccines and whole inactivated vaccines, can be difficult to manufacture, may cause severe side effects, and can potentially induce severe infection. Subunit vaccines carry far fewer safety concerns due to their inability to cause vaccine‐based infections. The applicability of protein nanoparticles (NPs) as vaccine scaffolds is promising to prevent infectious diseases, and they have been explored for a number of viral, bacterial, fungal, and parasitic diseases. Many types of protein NPs exist, including self‐assembling NPs, bacteriophage‐derived NPs, plant virus‐derived NPs, and human virus‐based vectors, and these particular categories will be covered in this review. These vaccines can elicit strong humoral and cellular immune responses against specific pathogens, as well as provide protection against infection in a number of animal models. Furthermore, published clinical trials demonstrate the promise of applying these NP vaccine platforms, which include bacteriophage‐derived NPs, in addition to multiple viral vectors that are currently used in the clinic. The continued investigations of protein NP vaccine platforms are critical to generate safer alternatives to current vaccines, advance vaccines for diseases that currently lack effective prophylactic therapies, and prepare for the rapid development of new vaccines against emerging infectious diseases.

    This article is categorized under:

    Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease

    Biology‐Inspired Nanomaterials > Protein and Virus‐Based Structures

     
    more » « less
  3. Abstract

    Human activities have increased the intensity and frequency of natural stressors and created novel stressors, altering host–pathogen interactions and changing the risk of emerging infectious diseases. Despite the ubiquity of such anthropogenic impacts, predicting the directionality of outcomes has proven challenging. Here, we conduct a review and meta‐analysis to determine the primary mechanisms through which stressors affect host–pathogen interactions and to evaluate the impacts stress has on host fitness (survival and fecundity) and pathogen infectivity (prevalence and intensity). We assessed 891 effect sizes from 71 host species (representing seven taxonomic groups) and 78 parasite taxa from 98 studies. We found that infected and uninfected hosts had similar sensitivity to stressors and that responses varied according to stressor type. Specifically, limited resources compromised host fecundity and decreased pathogen intensity, while abiotic environmental stressors (e.g., temperature and salinity) decreased host survivorship and increased pathogen intensity, and pollution increased mortality but decreased pathogen prevalence. We then used our meta‐analysis results to develop susceptible–infected theoretical models to illustrate scenarios where infection rates are expected to increase or decrease in response to resource limitations or environmental stress gradients. Our results carry implications for conservation and disease emergence and reveal areas for future work.

     
    more » « less
  4. Abstract

    Infectious diseases that result from pathogen infection are among the leading causes of human death, with pathogens such as human immunodeficiency virus, malaria, influenza, and ongoing SARS‐COV‐2 viruses constantly threatening the global population. While the mechanisms behind various infectious diseases are not entirely clear and thus retard the development of effective therapeutics, vaccines have served as a universal approach to containing infectious diseases. However, conventional vaccines that solely consist of antigens or simply mix antigens and adjuvants have failed to control various highly infective or deadly pathogens. Biomaterials‐based vaccines have provided a promising solution due to their ability to synergize the function of antigens and adjuvants, troubleshoot delivery issues, home and manipulate immune cells in situ. In this review, we will summarize different types of materials‐based vaccines for generating cellular and humoral responses against pathogens and discuss the design criteria for amplifying the efficacy of materials‐based vaccines against infectious diseases.

    This article is categorized under:

    Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease

     
    more » « less
  5. Abstract

    Zoonotic diseases represent 75% of emerging infectious diseases worldwide, and their emergence is mainly attributed to human‐driven changes in landscapes. Land use change, especially the conversion of natural areas to agricultural use, has the potential to impact hosts and vector dynamics, affecting pathogen transmission risk. While these links are becoming better understood, very few studies have investigated the opposite question—how native vegetation restoration affects zoonotic disease outbreaks.

    We reviewed the existing evidence linking native vegetation restoration with zoonotic transmission risk, identified knowledge gaps, and, by focusing on tropical areas, proposed forest restoration strategies that could help in limiting the spread of zoonotic diseases.

    We identified a large gap in information on the effects of native vegetation restoration on zoonotic diseases, especially within tropical regions. In addition, the few studies that exist do not consider environmental aspects that can affect the outcomes of restoration on disease risk, such as the land use history and landscape structural characteristics (as composition and configuration of native habitats). Our conceptual framework raises two important points: (1) the effects of forest restoration may depend on the context of the existing landscape, especially the percentage of native vegetation existing at the beginning of the restoration; and (2) these effects will also be dependent on the spatial arrangement of the restored area within the existing landscape. Furthermore, we propose important topics to be studied in the coming years to integrate zoonotic disease risk as a criterion in restoration planning.

    Synthesis and application. Our results contribute to a more comprehensive forest restoration planning, comprising multiple ecosystem services and resulting in healthier landscapes for both people and nature. Our framework could be integrated into the post‐2020 global biodiversity framework targets.

     
    more » « less